Nteliopoulos, G., Bazeos, A., Claudiani, S., Gerrard, G., Curry, E., Szydlo, R., Alikian, M., Foong, H. E., Nikolakopoulou, Z., Loaiza, S., Khorashad, J. S., Milojkovic, D., Perrotti, D., Gale, R. P., Foroni, L. and Apperley, J. F. (2019) “Somatic variants in epigenetic modifiers can predict failure of response to imatinib but not to second-generation tyrosine kinase inhibitors”, Haematologica. Pavia, Italy, 104(12), pp. 2400-2409. doi: 10.3324/haematol.2018.200220.